CERAMENT®
Bone void filling in benign bone tumors (e.g., simple bone cysts)
Key Facts
About Bonesupport Holding AB
Bonesupport Holding AB is a commercial-stage orthobiologics company focused on improving outcomes in bone infection and complex trauma through its proprietary CERAMENT® technology platform. The company's core innovation is an injectable, osteoconductive calcium sulfate/hydroxyapatite bone graft that can be loaded with antibiotics for local delivery. With regulatory approvals in key markets and a growing commercial footprint, Bonesupport aims to become a leader in the management of bone infections and complex fractures, leveraging clinical data demonstrating reduced infection recurrence and improved healing.
View full company profileAbout Bonesupport Holding AB
Bonesupport Holding AB is a commercial-stage orthobiologics company focused on improving outcomes in bone infection and complex trauma through its proprietary CERAMENT® technology platform. The company's core innovation is an injectable, osteoconductive calcium sulfate/hydroxyapatite bone graft that can be loaded with antibiotics for local delivery. With regulatory approvals in key markets and a growing commercial footprint, Bonesupport aims to become a leader in the management of bone infections and complex fractures, leveraging clinical data demonstrating reduced infection recurrence and improved healing.
View full company profile